Immunophenotypic measurable residual disease (MRD) in acute myeloid leukemia: Is multicentric MRD assessment feasible?
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference44 articles.
1. Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML;Lowenberg;Blood,2017
2. When the minimal becomes measurable;Hourigan;J. Clin. Oncol.,2016
3. Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia;Cheson;J. Clin. Oncol.,2003
4. Characterization of aberrant phenotypes in acute myeloblastic leukemia;Macedo;Ann. Hematol.,1995
5. How and why minimal residual disease studies are necessary in leukemia: a review from WP10 and WP12 of the European LeukaemiaNet;Bene;Haematologica,2009
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Flow cytometry in acute myeloid leukemia and detection of minimal residual disease;Clinica Chimica Acta;2025-01
2. Measurable Residual Disease Detection in Acute Myeloid Leukemia: Current Challenges and Future Directions;Biomedicines;2024-03-07
3. Minimal residual disease monitoring in acute myeloid leukemia: Focus on MFC‐MRD and treatment guidance for elderly patients;European Journal of Haematology;2024-02-11
4. Single-Cell Next-Generation Sequencing to Monitor Hematopoietic Stem-Cell Transplantation: Current Applications and Future Perspectives;Cancers;2023-04-26
5. Current and Emerging Techniques for Diagnosis and MRD Detection in AML: A Comprehensive Narrative Review;Cancers;2023-02-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3